Imaging the Stromal Vascular Fraction during Soft-Tissue Reconstruction
- PMID: 26595017
- DOI: 10.1097/PRS.0000000000001815
Imaging the Stromal Vascular Fraction during Soft-Tissue Reconstruction
Erratum in
-
Imaging the Stromal Vascular Fraction during Soft-Tissue Reconstruction: Correction.Plast Reconstr Surg. 2023 Dec 1;152(6):1380. doi: 10.1097/PRS.0000000000011174. Epub 2023 Nov 29. Plast Reconstr Surg. 2023. PMID: 38019693 No abstract available.
Abstract
Background: Although fat grafting is an increasingly popular practice, suboptimal volume retention remains an obstacle. Graft enrichment with the stromal vascular fraction has gained attention as a method of increasing graft retention. However, few studies have assessed the fate and impact of transplanted stromal vascular fraction on fat grafts. In vivo imaging techniques can be used to help determine the influence stromal vascular fraction has on transplanted fat.
Methods: Stromal vascular fraction was labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide (DiR), a near-infrared dye, and tracked in vivo. Proliferation and differentiation of labeled cells were assessed to confirm that labeling did not adversely affect cellular function. Different doses of labeled stromal vascular fraction were tracked within fat grafts over time using the in vivo imaging system.
Results: No significant differences in differentiation and proliferation were observed in labeled versus unlabeled cells (p > 0.05). A pilot study confirmed that stromal vascular fraction fluorescence was localized to fat grafts and different cell doses could be distinguished. A larger-scale in vivo study revealed that stromal vascular fraction fluorescence was statistically significant (p < 0.05) between different cell dose groups and this significance was maintained in higher doses (3 × 10(6) and 2 × 10(6) cells/ml of fat graft) for up to 41 days in vivo.
Conclusions: DiR labeling allowed the authors to differentiate between cell doses and confirm localization. This article supports the use of DiR labeling in conjunction with in vivo imaging as a tool for imaging stromal vascular fraction within fat grafts.
References
-
- Arcuri F, Brucoli M, Baragiotta N, et al. The role of fat grafting in the treatment of posttraumatic maxillofacial deformities. Craniomaxillofac Trauma Reconstr. 2013;6:121–126
-
- Philips BJ, Grahovac TL, Valentin JE, et al. Prevalence of endogenous CD34+ adipose stem cells predicts human fat graft retention in a xenograft model. Plast Reconstr Surg. 2013;132:845–858
-
- Zhu M, Zhou Z, Chen Y, et al. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg. 2010;64:222–228
-
- Leblanc AJ, Nguyen QT, Touroo JS, et al. Adipose-derived cell construct stabilizes heart function and increases microvascular perfusion in an established infarct. Stem Cells Transl Med. 2013;2:896–905
-
- Matsumoto D, Sato K, Gonda K, et al. Cell-assisted lipotransfer: Supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng. 2006;12:3375–3382
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources